Filing Details
- Accession Number:
- 0000899243-22-000176
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-03 19:50:25
- Reporting Period:
- 2021-12-29
- Accepted Time:
- 2022-01-03 19:50:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1110744 | Fred Hassan | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-29 | 19,300 | $14.17 | 19,300 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price of the shares purchased from $14.1250 to $14.2300 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote.
Billionaire Hedge Funds
